FC Barcelona, CELLINK and Leitat join TRIANKLE project to regenerate ankle joints with bioprinting

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

The TRIANKLE consortium will develop 3D bioprinted personalized scaffolds for tissue regeneration of ankle joints. High profile consortium partners include bioprinting firm CELLINK, Barcelona-based technological center Leitat and the popular sports club FC Barcelona.

Barça is taking part in the project through the health area of ​​the Barça Innovation Hub. The club’s main role will be to perform preclinical assessments of these implants and offer evaluations of patient groups such as its amateur athletes and the FC Barcelona Players Association, as well as contribute to the dissemination and promotion of the program. It all fits perfectly with one of the principles of the BIHUB, for its projects contribute not only to improving the club, but also the world of sport and society at large. 

This ambitious research project in regenerative medicine has an overall budget of €5.9M and will be developed over 4 years, starting in January 2021. CELLINK´s portion of the grant is. €622,000 of which the EU accounts for 100 percent of the costs. With CELLINK’s support, the consortium aims to create innovative personalized collagen- and gelatine-based implants manufactured with 3D bioprinting technology for patients with tendinopathies such as Achilles tendon partial ruptures and cartilage injuries.

Overall, TRIANKLE consortium consists of a team of 12 organizations covering the complete spectrum from advanced research to the market. Its main strength relies on the combination of highly skilled partners with proven track records in biomaterials for regenerative applications and 3D bioprinting technology. Partners are also devoted to social engagement and dissemination of results to healthcare professionals and, ultimately, potential patients.

The partnership includes one industry partner (Naturin Viscofan GmbH), three SMEs (CELLINK AB, Cambridge Nanomaterials Technology, and Gradocell SL), two research centres (Fraunhofer Gesellschaft Zur Foerderung Der Angewandten Forschung E.V. and Acondicionamiento Tarrasense Associacion), three universities (University of Stuttgart, Universidad del País Vasco and Eindhoven University of Technology), two non-profit organisations (Futbol Club Barcelona Asociacion FCB and Osteoarthritis Foundation International OAFI) and one healthcare institution (Fundacio Clinic per a la Recerca Biomedica). The TRIANKLE project coordinator is Naturin Viscofan GmbH.

The TRIANKLE project is working to unlock the potential of innovative 3D printing technology for regenerative medical applications and ultimately enable the commercialization of personalized regenerative solutions. Furthermore, the innovation potential of TRIANKLE lies in the launching of the technological platform that will enable the development of future regenerative therapies of joint tissues in weight-bearing joints.

Research 2022
Polymer AM Market Opportunities and Trends

741 unique polymer AM companies individually surveyed and studied. Core polymer AM market generated $4.6 billion...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based 3dpbm. Today the company publishes the leading news and insights websites 3D Printing Media Network and Replicatore, as well as 3D Printing Business Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Back to top button

We use cookies to give you the best online experience and for ads personalisation. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services



Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*